HomeInsightsPE

Abbott India Ltd PE Ratio

Abbott India Ltd PE Ratio

stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

0.3 K

stocks traded

Last Updated time: 30 Oct 9.00 AM

Image

Abbott India Ltd

NSE: ABBOTINDIA

PE

48.7

Last updated on: Oct 30, 2024

Key Highlights

  • The P/E Ratio of Abbott India Ltd is 48.7 as of 30 Oct 9.00 AM.
  • The P/E Ratio of Abbott India Ltd changed from 34.4 on March 2019 to 47.7 on March 2024 . This represents a CAGR of 5.60% over 6 years. .
  • The Latest Trading Price of Abbott India Ltd is ₹ 28394 as of 30 Oct 15:30.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Abbott India Ltd

No data available

Company Fundamentals for Abbott India Ltd

No data available

Image

Abbott India Ltd

NSE: ABBOTINDIA

PRICE

28394.65

-106.60 (-0.37%)

stock direction

Last updated on: Oct 30 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Abbott India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
30 Oct 202428394.65
29 Oct 202428501.25
28 Oct 202428405.85
25 Oct 202428526.15
24 Oct 202428618.8
23 Oct 202428467.8
22 Oct 202429026.8
21 Oct 202429178.7
18 Oct 202429196.1
17 Oct 202428416.2

SWOT Analysis Of Abbott India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Abbott India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Abbott India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Abbott India Ltd4860,338
Sun Pharmaceuticals Industries Ltd394,44,465
Divis Laboratories Ltd931,56,264
Cipla Ltd241,14,473
Torrent Pharmaceuticals Ltd611,06,171
Mankind Pharma Ltd531,05,299

Key Valuation Metric of Abbott India Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Abbott India Ltd

No data available

* All values are in crore

Historical Revenue of Abbott India Ltd

No data available

* All values are in crore

Historical EBITDA of Abbott India Ltd

No data available

* All values are in crore

Historical Net Profit of Abbott India Ltd

No data available

* All values are in crore

Historical Dividend Payout of Abbott India Ltd

No data available

* All values are in %

About Abbott India Ltd

  • Abbott India Ltd. is one of the leading multinational pharmaceutical companies in India and operates with an owned manufacturing facility in Goa and various independent contract/third party manufacturers based across the country.
  • The Company sells its products through independent distributors primarily within India.
  • It provides products and solutions across various therapeutic areas such as Women's Health, Gastroenterology, Central Nervous System, Metabolics, Multi-Specialty, Vaccines, Consumer Health, etc.
  • Its global products include Brufen, Prothiaden, Thyronorm and Leptos. The company has four divisions.
  • The Primary Care division markets products in the areas of pain management and gastroenterology.

Abbott India Ltd News Hub

News

Abbott India standalone net profit rises 13.01% in the June 2024 quarter

Net profit of Abbott India rose 13.01% to Rs 328.01 crore in the quarter ended June 2024 a...

Read more

2024-08-08 00:00:00

News

Sensex, Nifty hit new life highs; auto shares in demand

The key equity indices further extended gains and hit fresh record highs in mid-morning tr...

Read more

2024-09-20 00:00:00

News

Abbott India joins hand with Takeda Pharma to launch Vonoprazan tablets in India

Vonoprazan (PCAB or potassium competitive acid blocker) addresses severe acid related diso...

Read more

2024-09-20 00:00:00

News

Abbott India director resigns

Abbott India announced the resignation of Ashok Saini as Commercial Director - GenNext, Va...

Read more

2024-10-18 00:00:00

News

Abbott India to announce Quarterly Result

Abbott India will hold a meeting of the Board of Directors of the Company on 7 November 20...

Read more

2024-10-29 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Abbott India Ltd

What is the current PE Ratio of Abbott India Ltd?

The Current PE Ratio of Abbott India Ltd is 48.7 as on 30 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 30 Oct 2024.

What was the PE Ratio of Abbott India Ltd last year?

The PE Ratio of Abbott India Ltd was 49.43 last year, now the PE ratio is 48.7, showing a year-on-year growth of -1.5%.

What does the PE Ratio of Abbott India Ltd indicate about its stock?

The PE Ratio of Abbott India Ltd is 48.7. This ratio indicates that investors are willing to pay 48.7 times the earnings per share for each share of Abbott India Ltd.

What is the PE Ratio Growth of Abbott India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Abbott India Ltd grew by -1.5% whereas, the EPS ratio grew by 14.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*